William Blair initiated coverage of Pennant Group (PNTG) with an Outperform rating. The firm views Pennant as an attractive small-cap growth investment and notes that shares trade at a multiple toward the low end of healthcare services peers, presenting what the firm views as an attractive risk/reward profile given Pennant’s durable long-term growth outlook.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PNTG:
- Buy Rating for Pennant Group: Strong Growth Potential and Attractive Valuation
- Pennant Group upgraded to Buy from Hold at Truist
- Wells Fargo says CMS final rule positive for Pennant Group, BrightSpring Health
- CMS announces final rule for home health prospective payment system
- Amazon downgraded, Alphabet upgraded: Wall Street’s top analyst calls